Remove about responsibility responsible-business
article thumbnail

Pharma’s corporate social responsibility?

World of DTC Marketing

What is pharma’s responsibility? Pfizer has made billions of dollars from their COVID vaccine but shouldn’t they have a responsibility to warn people that obesity is a leading cause of severe COVID? What about insurers? There is a slow transition happening in corporate America; social responsibility.

article thumbnail

Treg Cell Therapy for Neurodegenerative Diseases – Interview with Dr. Howard Berman, CEO, Coya Therapeutics – Xtalks Life Science Podcast Ep. 155

XTalks

Berman has over 18 years of entrepreneurial and industry experience working at the interplay of science and business. His experience offers him a unique combination of business acumen and scientific credibility with the ability to assess, quantify and bridge both disciplines.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pressure is building on pharma and biotech companies to take climate action

STAT News

As the health impacts of climate change become harder to ignore, biotechnology and pharmaceutical companies are facing increasing pressure from investors, employees, and government regulators to reduce their carbon emissions, and to make environmental sustainability a core part of their business. about 8.5% In the U.S.,

article thumbnail

Personal responsibility in our healthcare

World of DTC Marketing

IN BRIEF: At some point, we need to realize that good health is our personal responsibility. Responsibility for health should be a collaborative effort among individuals and the societies in which they live. The call for personal responsibility is not new, nor just conservative. About 9 in 10 cases in the U.S.

article thumbnail

The Power of Personalization Amid the Changing CRO Landscape

Worldwide Clinical Trials

Among the responses included: At Worldwide, we’re a CRO that prides ourselves on our personalized approach, providing direct access to our therapeutic experts while maintaining operational rigor. From our agility and responsiveness to rapid issue resolution via senior leaders, we’re excited to work with you on your next clinical trial.

article thumbnail

Business optimism improves in June 2022: Poll

Pharmaceutical Technology

Business optimism improved in June 2022 compared to May 2022, even amid concerns over rising costs and slowing demand, revealed an analysis of an ongoing poll by Verdict. Analysis of the poll responses recorded in June 2022 shows that optimism regarding future growth prospects increased by five percentage points to 63% from 58% in May 2022.

article thumbnail

Revolutionizing Orthopedic Joint Replacement — Interview with Ben Sexson, Co-Founder, CEO, Monogram Orthopedics – Xtalks Life Science Podcast Ep. 142

XTalks

Ben is an engineer by training and before joining Monogram, he served as the Director of Business Development at Pro-Dex, an OEM manufacturer of Orthopedic Robotic End-Effectors. Monogram is focused on developing patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging.